Global Estriol Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Estriol Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.
Estriol report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Estriol market is projected to reach US$ 4 million in 2034, increasing from US$ 3 million in 2022, with the CAGR of 4.2% during the period of 2024 to 2034. Demand from Pharmaceutical and Biological Research are the major drivers for the industry.
The leading producers in the sector are Jiangxi Yuneng Pharmaceutical, Shanghai Lianlu Industry and Jiangsu Yuanda SYM Pharmaceutical, with revenues of 28.20 percent, 13.44 percent and 21.48 percent respectively in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Estriol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Jiangxi Yuneng Pharmaceutical
Shanghai Lianlu Industry
Jiangsu Yuanda SYM Pharmaceutical
Segment by Type
Purity<99%
Purity≥99%
Pharmaceutical
Biological Research
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Asia-Pacific
China
Japan
South Korea
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Estriol market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Estriol, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Estriol industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Estriol in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Estriol introduction, etc. Estriol Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Estriol market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Estriol report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Estriol market is projected to reach US$ 4 million in 2034, increasing from US$ 3 million in 2022, with the CAGR of 4.2% during the period of 2024 to 2034. Demand from Pharmaceutical and Biological Research are the major drivers for the industry.
The leading producers in the sector are Jiangxi Yuneng Pharmaceutical, Shanghai Lianlu Industry and Jiangsu Yuanda SYM Pharmaceutical, with revenues of 28.20 percent, 13.44 percent and 21.48 percent respectively in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Estriol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Jiangxi Yuneng Pharmaceutical
Shanghai Lianlu Industry
Jiangsu Yuanda SYM Pharmaceutical
Segment by Type
Purity<99%
Purity≥99%
Segment by Application
Pharmaceutical
Biological Research
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Asia-Pacific
China
Japan
South Korea
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Estriol market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Estriol, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Estriol industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Estriol in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Estriol introduction, etc. Estriol Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Estriol market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.